Matches in SemOpenAlex for { <https://semopenalex.org/work/W3128783047> ?p ?o ?g. }
- W3128783047 abstract "Summary Convalescent plasma may benefit immunocompromised individuals with COVID-19, including those with hematologic malignancy. We evaluated the association of convalescent plasma treatment with 30-day mortality in hospitalized adults with hematologic malignancy and COVID-19 from a multi-institutional cohort. 143 treated patients were compared to 823 untreated controls. After adjustment for potential confounding factors, convalescent plasma treatment was associated with improved 30-day mortality (hazard ratio, 0.60; 95% CI, 0.37-0.97). This association remained significant after propensity-score matching (hazard ratio, 0.52; 95% CI, 0.29-0.92). These findings suggest a potential survival benefit in the administration of convalescent plasma to patients with hematologic malignancy and COVID-19." @default.
- W3128783047 created "2021-02-15" @default.
- W3128783047 creator A5003892243 @default.
- W3128783047 creator A5015686436 @default.
- W3128783047 creator A5016088302 @default.
- W3128783047 creator A5030872984 @default.
- W3128783047 creator A5031234862 @default.
- W3128783047 creator A5035803024 @default.
- W3128783047 creator A5043557974 @default.
- W3128783047 creator A5044194506 @default.
- W3128783047 creator A5046802227 @default.
- W3128783047 creator A5047806708 @default.
- W3128783047 creator A5051337497 @default.
- W3128783047 creator A5058746837 @default.
- W3128783047 creator A5059656568 @default.
- W3128783047 creator A5060452476 @default.
- W3128783047 creator A5060678556 @default.
- W3128783047 creator A5061376402 @default.
- W3128783047 creator A5063024680 @default.
- W3128783047 creator A5066717552 @default.
- W3128783047 creator A5067095683 @default.
- W3128783047 creator A5068938722 @default.
- W3128783047 creator A5079808194 @default.
- W3128783047 creator A5082946065 @default.
- W3128783047 date "2021-02-05" @default.
- W3128783047 modified "2023-10-01" @default.
- W3128783047 title "Convalescent Plasma and Improved Survival in Patients with Hematologic Malignancies and COVID-19" @default.
- W3128783047 cites W2074305256 @default.
- W3128783047 cites W2111635289 @default.
- W3128783047 cites W2121690051 @default.
- W3128783047 cites W2148822770 @default.
- W3128783047 cites W3011379523 @default.
- W3128783047 cites W3021590963 @default.
- W3128783047 cites W3021816206 @default.
- W3128783047 cites W3030573714 @default.
- W3128783047 cites W3037848912 @default.
- W3128783047 cites W3044508572 @default.
- W3128783047 cites W3044623713 @default.
- W3128783047 cites W3081513395 @default.
- W3128783047 cites W3084288438 @default.
- W3128783047 cites W3087063072 @default.
- W3128783047 cites W3087511084 @default.
- W3128783047 cites W3091936244 @default.
- W3128783047 cites W3103751847 @default.
- W3128783047 cites W3104697496 @default.
- W3128783047 cites W3110542218 @default.
- W3128783047 cites W3111140326 @default.
- W3128783047 cites W3119294059 @default.
- W3128783047 doi "https://doi.org/10.1101/2021.02.05.21250953" @default.
- W3128783047 hasPublicationYear "2021" @default.
- W3128783047 type Work @default.
- W3128783047 sameAs 3128783047 @default.
- W3128783047 citedByCount "15" @default.
- W3128783047 countsByYear W31287830472021 @default.
- W3128783047 countsByYear W31287830472022 @default.
- W3128783047 crossrefType "posted-content" @default.
- W3128783047 hasAuthorship W3128783047A5003892243 @default.
- W3128783047 hasAuthorship W3128783047A5015686436 @default.
- W3128783047 hasAuthorship W3128783047A5016088302 @default.
- W3128783047 hasAuthorship W3128783047A5030872984 @default.
- W3128783047 hasAuthorship W3128783047A5031234862 @default.
- W3128783047 hasAuthorship W3128783047A5035803024 @default.
- W3128783047 hasAuthorship W3128783047A5043557974 @default.
- W3128783047 hasAuthorship W3128783047A5044194506 @default.
- W3128783047 hasAuthorship W3128783047A5046802227 @default.
- W3128783047 hasAuthorship W3128783047A5047806708 @default.
- W3128783047 hasAuthorship W3128783047A5051337497 @default.
- W3128783047 hasAuthorship W3128783047A5058746837 @default.
- W3128783047 hasAuthorship W3128783047A5059656568 @default.
- W3128783047 hasAuthorship W3128783047A5060452476 @default.
- W3128783047 hasAuthorship W3128783047A5060678556 @default.
- W3128783047 hasAuthorship W3128783047A5061376402 @default.
- W3128783047 hasAuthorship W3128783047A5063024680 @default.
- W3128783047 hasAuthorship W3128783047A5066717552 @default.
- W3128783047 hasAuthorship W3128783047A5067095683 @default.
- W3128783047 hasAuthorship W3128783047A5068938722 @default.
- W3128783047 hasAuthorship W3128783047A5079808194 @default.
- W3128783047 hasAuthorship W3128783047A5082946065 @default.
- W3128783047 hasBestOaLocation W31287830471 @default.
- W3128783047 hasConcept C126322002 @default.
- W3128783047 hasConcept C17923572 @default.
- W3128783047 hasConcept C207103383 @default.
- W3128783047 hasConcept C2779134260 @default.
- W3128783047 hasConcept C2779399171 @default.
- W3128783047 hasConcept C2909984355 @default.
- W3128783047 hasConcept C3008058167 @default.
- W3128783047 hasConcept C3018027319 @default.
- W3128783047 hasConcept C44249647 @default.
- W3128783047 hasConcept C50382708 @default.
- W3128783047 hasConcept C524204448 @default.
- W3128783047 hasConcept C71924100 @default.
- W3128783047 hasConcept C72563966 @default.
- W3128783047 hasConcept C77350462 @default.
- W3128783047 hasConceptScore W3128783047C126322002 @default.
- W3128783047 hasConceptScore W3128783047C17923572 @default.
- W3128783047 hasConceptScore W3128783047C207103383 @default.
- W3128783047 hasConceptScore W3128783047C2779134260 @default.
- W3128783047 hasConceptScore W3128783047C2779399171 @default.
- W3128783047 hasConceptScore W3128783047C2909984355 @default.
- W3128783047 hasConceptScore W3128783047C3008058167 @default.